AstraZeneca Partners With AmoyDx On Companion Diagnostics For Lynparza
Executive Summary
Teaming again with the Shanghai biotech, AstraZeneca will seek assays that can be incorporated into companion diagnostics for Lynparza in prostate and breast cancer.
You may also be interested in...
How To Comply With New Requirements For Companion Diagnostics Under IVDR
The regulation of companion diagnostics will be far stricter under the IVDR than the current IVD Regulation. EU life sciences regulatory lawyer Elisabethann Wright provides an overview and explains how companies should prepare for compliance.
Foundation Medicine Obtains FDA Approval For Non Small Cell Lung Cancer Companion Diagnostic
Foundation Medicine and Novartis’ commercial partnership has achieved another success as Foudation’s Liquid CDx is approved.
Guardant Health, Roche’s Foundation Medicine Receive FDA Companion Diagnostic Nods
Roche’s Foundation Medicine still leads Guardant Health in terms of total companion-diagnostic US FDA approvals as both companies announced new PMA supplements.